Kaken Pharmaceutical Co., Ltd. (4521.T)
Kaken Pharmaceutical Co., Ltd.
3,875.00-0.01%Healthcare
StockGlow Score
Neutral
BearishBullish
1 year ago-2.7%
The outlook
Kaken Pharmaceutical Co., Ltd. currently reads as neutral based on hold — 2.8 avg of 4 analysts, mixed vs its moving averages, 37% of the way from its 52-week low to high, avg target +16% vs current price. This is a snapshot of current market data, not a forecast.
What’s behind the score
Analyst consensusHold — 2.8 avg of 4 analysts
Price trendMixed vs its moving averages
52-week range37% of the way from its 52-week low to high
Price targetAvg target +16% vs current price
Analyst price target
~12-month · 4 analysts4,500.00average target+16.1% vs now
Now 3,875.00
Low 4,000.00High 5,300.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$146.74B
52-wk high
4,445.00
52-wk low
3,540.00
50-day avg
3,869.20
200-day avg
3,994.50
Trailing P/E
68.3